The US is paying digital diagnostics firm Ellume Ltd. $231.8m to to build a factory to boost production of its COVID-19 at-home diagnostic test that provides results in 15 minutes and is available nonprescription.
Until the facility is built for the Australian firm's Ellume USA LLC business based in Valencia, CA, the US will receive half the tests it